ECL vs ELDN · P/E 35, rev $4.01B vs $209.6M cap
Ecolab Inc (ECL) versus Eledon Pharmaceuticals Inc (ELDN) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Eledon Pharmaceuticals Inc (ELDN) is a biotechnology company listed on US.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
ELDN does not have a complete income-statement cache yet.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. ELDN currently screens at market cap $209.6M.
Not investment advice. Open the ECL and ELDN stock pages for the full models.
Not investment advice.